#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group

From metformin to basal insulin to overlooked older medications, this episode reviews the T2D medication toolkit clinicians use every day. We then dive into new evidence on once-weekly insulin to help you individualize therapy while reducing treatment burden. 🔹 Sponsor : Pain Management and Opioids Adaptive Learning Free Online Course by NEJM Group: 🔹 Transcript and Shownotes : 00.58 | Insulin Hx & Types 06:00 | Indications for Insulin and the Burden on Patients 08:26 | What is the QWINT-1 Trial? 16:18 | Discussion Tags: CoreIM, Internal Medicine, Evidence-Based Medicine, Insulin Resistance, Clinical Reasoning, Hospital Medicine, Medical Education, Endocrine, Endocrinology Find the best disability insurance for you: Our Sponsors: * Check out FIGS: * Click for 15% off Premium Starter Kit at Branch Basics: Advertising Inquiries: Privacy & Opt-Out:

You can listen to #200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group online on Radio and Podcast. Open the player on this page to stream the available audio.

#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group is an episode from Core IM | Internal Medicine Podcast by Core IM Team.

This episode is 28:14 long.

This episode was published on Feb 11, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Core IM | Internal Medicine Podcast when more episodes are available from the podcast feed.